SCHEMBL2438259

SCHEMBL2438259

COC(=O)Cn1nc(-c2ccc(Cl)cc2)n(Cc2cccc(C(=O)O)c2C)c1=O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AVPR2 P30518 7/20 0.46
AVPR1A P37288 7/20 0.46
CYP1A2 P05177 1/20 0.43
GAA P10253 1/20 0.43
CYP2C19 P33261 1/20 0.43
CNR1 P21554 1/20 0.41
MAPT P10636 2/20 0.40
MRGPRX4 Q96LA9 1/20 0.40
TSHR P16473 2/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CMA1 P23946 1/20 0.38
CNR2 P34972 1/20 0.38
P2RX3 P56373 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18783452 0.88 AVPR2 (0.47) AVPR2AVPR1ACNR1
SCHEMBL8232476 0.83 AVPR2 (0.61) AVPR2AVPR1ACYP1A2GAACYP2C19
SCHEMBL2438261 0.78 AVPR2 (0.49) AVPR2AVPR1ACNR1MAPTLMNA
SCHEMBL18783440 0.78 AVPR2 (0.56) AVPR2AVPR1ACNR1MRGPRX4
SCHEMBL2500581 0.77 AVPR2 (0.70) AVPR2AVPR1A
SCHEMBL8227135 0.76 AVPR2 (0.47) AVPR2AVPR1ACYP1A2GAACYP2C19
SCHEMBL8233090 0.76 AVPR2 (0.49) AVPR2AVPR1ACYP1A2GAACYP2C19
SCHEMBL8235892 0.75 AVPR2 (0.49) AVPR2AVPR1ACYP1A2GAACYP2C19
SCHEMBL8739607 0.75 AVPR2 (0.53) AVPR2AVPR1ACYP1A2GAACYP2C19
SCHEMBL18783444 0.74 AVPR2 (0.45) AVPR2AVPR1ACMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2539326-B1 BISARYL-BONDED ARYLTRIAZOLONES AND USE THEREOF BAYER IP GMBH (DE) 2017-05-03 EP disclosed
WO-2011104322-A1 BISARYL-BONDED ARYLTRIAZOLONES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-09-01 WO disclosed